ABBOTT LABORATORIES — Director's Dealing 2018

Sep 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-09-05

Reporting Person: Funck Robert E (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-05	Common shares without par value	M	9700	$26.1879	Acquired	118380	Direct
2018-09-05	Common shares without par value	M	12300	$22.3919	Acquired	130680	Direct
2018-09-05	Common shares without par value	M	14400	$27.0336	Acquired	145080	Direct
2018-09-05	Common shares without par value	F	23751	$67.11	Disposed	121329	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-05	Option (right to buy)	$26.1879	M	9700	Disposed	2020-02-18	Common shares (9700)	Direct
2018-09-05	Option (right to buy)	$22.3919	M	12300	Disposed	2021-02-17	Common shares (12300)	Direct
2018-09-05	Option (right to buy)	$27.0336	M	14400	Disposed	2022-02-16	Common shares (14400)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	17157	Indirect
Common shares without par value	500	Indirect
Common shares without par value	500	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of September 5, 2018.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.